Khalifa Kush, a cannabis brand founded bymulti-platinum-selling, GRAMMY and Golden Globe-nominated recording artistWiz Khalifa,is coming to Europe. Starting in early 2025, Khalifa Kush will enter theGerman medical cannabis marketthrough a strategic multi-year partnership with Berlin-basedSanity Groupand its leading medical cannabis brand,avaay Medical.
Beginning inJanuary 2025, avvay will introduce two exclusive Khalifa Kush strains in the form of flower as a medical offering to German patients, with additional strain launches to follow throughout the year. Grown under GACP-certified conditions, these strains were specifically produced for the German market...
Login or create a forever free account to read this news
Sign up/Log in